Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andreas Wilmen
Observed names:
A Wilmen,
A. WILMEN,
A. Wilmen,
Wilmen Andreas
Institution:
Bayer (Germany)
Observed institutions:
University College London Hospitals NHS Foundation Trust,
Philipps University of Marburg,
Justus-Liebig-Universität Gießen,
University College London,
Bayer (Germany),
University of Pennsylvania
show all 6
OpenAlex ID:
A5090054497
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor
2005
·
E. PERZBORN
, J. STRASSBURGER
, et al.
·
Journal of Thrombosis and Haemostasis
·
597
PDF
Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression
2000
·
Kaimei Song
, Yiguang Chen
, et al.
·
The Journal of Experimental Medicine
·
363
PDF
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
2001
·
Brendan Hilliard
, Andreas Wilmen
, et al.
·
The Journal of Immunology
·
201
PDF
DUG is a novel homologue of translation initiation factor 4G that binds eIF4A
2002
·
Alexandra Göke
, Rüdiger Göke
, et al.
·
Biochemical and Biophysical Research Communications
·
93
Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI
2019
·
Martina Schaefer
, Anja Buchmueller
, et al.
·
Journal of Molecular Biology
·
74
PDF
The isolated N‐terminal extracellular domain of the glucagon‐like peptide‐1 (GLP)‐1 receptor has intrinsic binding activity
1996
·
Andreas Wilmen
, Burkhard Goke
, et al.
·
FEBS Letters
·
54
PDF
Five Out of Six Tryptophan Residues in the N -Terminal Extracellular Domain of the Rat GLP-1 Receptor Are Essential for its Ability to Bind GLP-1
1997
·
Andreas Wilmen
, Brigitte Van Eyll
, et al.
·
Peptides
·
45
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia
2020
·
Xiao-Yan Zhao
, Andreas Wilmen
, et al.
·
Nature Communications
·
42
PDF
Cpf1 protein induced bending of yeast centromere DNA element I
1993
·
Rainer K. Niedenthal
, Mark Sen-Gupta
, et al.
·
Nucleic Acids Research
·
42
Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function
1996
·
Brigitte Van Eyll
, Burkhard Göke
, et al.
·
Peptides
·
26
The yeast centromere CDEI/Cpf1 complex: differences betweenin vitrobinding andin vivofunction
1994
·
Andreas Wilmen
, Horst Pick
, et al.
·
Nucleic Acids Research
·
16
The genomic organization of the human GLP-1 receptor gene
2009
·
A. Wilmen
, A. Walkenbach
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
·
7
The chromatin of the Saccharomyces cerevisiae centromere shows cell-type specific changes
1996
·
Andreas Wilmen
, Johannes H. Hegemann
·
Chromosoma
·
5
Antibody BAY3018250 against antiplasmin enhances plasminogen activation in vitro and thrombolysis in rabbits
2026
·
C.J. Lindo
, Peng Liao
, et al.
·
Journal of Thrombosis and Haemostasis
·
1
Design of SIRIUS: a randomized placebo-controlled Phase II study of inclocibart, an antibody against α2-antiplasmin, for proximal deep vein thrombosis
2026
·
Jan Beyer-Westendorf
, Dirk Thomas
, et al.
·
TH Open
Adult Stem Cells in Drug Discovery
2010
·
Stefan Golz
, Andreas Geerts
, et al.
·
Springer eBooks
Differential regulation of pancreatic genes during experimental pancreatitis, investigated by differential display analysis
1998
·
A Wilmen
, M Strowski
, et al.
·
Gastroenterology
PDF
Show more works
View as search
Works count:
18
Citation count:
1,566
H-index:
11
I10-index:
11
Year
Topic
Type